BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Elder Pharmaceutical Ltd. Posts Higher Net Profit of Rs. 15.83 Cr for Q3 Ended Dec'10 – Up By 3%


2/7/2011 9:13:07 AM

Elder Pharmaceuticals Ltd (NSE– ELDERPHARM) an integrated pharmaceuticals company headquartered in Mumbai has posted excellent results for the third quarter ended Dec 2010 (Q3 FY2011). As per the consolidated unaudited provisional results taken on record on Feb 7th, 2011, the income from operations has gone up to Rs 251.54 Crore for Q3 FY2011 as compared to Rs. 179.99 Crore during the corresponding quarter in the previous year. The consolidated operating profit (PBIDT) too has gone up to Rs. 45.01 Crore for Q3 FY2011 reflecting a growth of 23% over the previous corresponding quarter’s figure of Rs. 36.50 Crore. The consolidated Net Profit too has gone up to Rs. 15.83 Crore (previous year’s quarter – Rs. 15.37 Crore) – a spurt of 3%. The consolidated EPS on a non – annualized basis comes to Re. 8.34.

For the nine months ended Dec 2010, the consolidated sales turnover is Rs. 656.48 Cr (previous nine months – Rs. 512.28 Cr) up by 28% and the net profit is Rs. 46.19 Cr (previous nine months – Rs 38.45 Cr) up by 20%.

During the quarter under review, Elder Pharma received accreditation from Ministry of Health-Japan for its API [Active Pharmaceutical Ingredients] plant at Patalganga, Maharashtra opening up the fast-growing Japanese markets for the companies products. This accreditation is considered to be very difficult to get as only companies with the very best of infrastructure and quality are able to get this accreditation. “This accreditation for the API plant is a step towards strengthening Elder’s position as a supplier of APIs and intermediates in the Japanese market,” informed Mr. Alok Saxena, Director, Elder Pharmaceuticals Limited.

The Company has launched Shelcal K which is a combination of Calcium with high dosage of Vitamin K, prescribed in severe established cases of osteoporosis with a pre-existing vertebral fracture. Contribution from the Langa Road facility (Uttaranchal), launch of new products, penetration into Rural & Semi-Urban markets and strong growth in the traditional products have contributed to the company’s better working.

Elder Pharmaceuticals has presence in niche therapeutic segments like Women’s healthcare, Wound care, Nutraceuticals /vitamin Supplements, Cardiology, Diabetes, Dermatology, Antibiotics and neurology. It is the market leader in calcium supplements (Shelcal), wound healing and injectable B12 vitamin. The company has a judicious mix of drug formulations, and active pharma ingredients (APIs). It has 6 manufacturing plants in India located in Maharashtra, Uttarakhand & Himachal Pradesh. The company has a state-of-the-art Research & Development Centre at Navi Mumbai which is recognized by the Department of Scientific & Industrial Research, Ministry of Science & Technology. (www.elderindia.com).

Mitesh M Kapadia +91 98205 03876 Sentinel Public Relations P Ltd / Sentinel Advertising Services Tel: (022) 28625131/32 Fax: (022) 28625133 Email: mitesh@publicrelationindia.com URL: www.publicrelationindia.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES